The Population Council seeks to improve the family planning and
reproductive health options of people throughout the world. To further this
end, the Council develops and evaluates promising ideas for new reproductive
health products. The Council conducts fundamental research on reproductive
and immunological processes, which serves as the basis for the development
of new contraceptive methods, hormone therapies, and AIDS-prevention
products. The Council's Intellectual
Asset Management group engages development and licensing partners, leading
to the commercial manufacture and marketing of finished products.
|
Registered products
|
|
Jadelle®: NDA 20-544/S-003
-
Two-rod subdermal implant for
contraception (more)
-
FDA approval
-
Approved labeling (PDF)
-
Letter from the FDA to the
Council documenting extension of the approved duration of use for the
prevention of pregnancy from “up to 3 years” to “up to 5 years”
(offsite
PDF)
-
Monograph summarizing
scientific data and lessons learned about marketing (PDF)
-
Available to license for
marketing in the United States
|
|
Nestorone®
implant
-
Single-rod subdermal implant for female contraception and hormone
replacement (more)
-
Approved in
Brazil
-
Phase 2 studies completed
-
Patent protection through
2015 (offsite
full text 1;
offsite full text 2)
-
Available for licensing worldwide
|
|
Progering® and Fertiring®
-
Progesterone vaginal ring for
contraception during lactation and hormone supplementation for in vitro
fertilization programs (more)
-
Approved in Chile and Peru (PDF)
-
Publications providing more details about
the progesterone vaginal ring (more)
-
Patent protection
through 2016 (offsite
full text)
-
Available for licensing
outside South America
|
|
Products in clinical trials |
|
Carraguard®
-
Vaginal microbicide for protection against
HIV transmission (more)
-
Phase 3 trials completed;
data analysis underway (offsite
full text)
-
Patent application filed in 2002 (offsite
full text)
-
Available for licensing
worldwide
|
|
Nestorone®/ethinyl estradiol ring
|
|
[Gln']-luteinizing
hormone-releasing hormone conjugate of tetanus vaccine and its uses
-
Phase 1
trial ongoing (more)
-
Patent protection through 2011 (offsite
full text)
-
Available for licensing
worldwide
|
|
Patented products
|
|
Transdermal Nestorone®
(more)
Nestorone® patch
Nestorone® gel
|
|
Lonidamine
-
Indazole
derivatives (more)
-
Early basic
research
-
Patent protection through 2019 (offsite
full text)
-
Available for licensing worldwide
|
|
Other patents and
patent applications
|
|
Occludin
|
|
Peptide nucleic acids
|
|
Isolated DNA molecule encoding SPRM-1 protein
|
|
Leydig cell stimulator
|
